Dystrophie musculaire de Duchenne Dystrophie musculaire de Duchenne Dystrophie musculaire de Duchenne

Archives

Monthly Archive for: "July, 2017"
Portait of Duchenne – repurposing existing drugs for DMD
By La Force DMD
In Research, Treatments
Posted 20 July 2017

Portait of Duchenne – repurposing existing drugs for DMD

Steve J. Winder, PhD Professor of Molecular Cell Biology, Director of Postgraduate Teaching, Director of External Relations, Department of Biomedical Science, The University of Sheffield, United [...]

Portait of Duchenne – Edasalonexent: The potential to modify DMD
By La Force DMD
In Treatments
Posted 10 July 2017

Portait of Duchenne – Edasalonexent: The potential to modify DMD

Joanne M. Donovan, MD, PhD Chief Medical Officer at Catabasis Pharmaceuticals, Cambridge, Massachusetts, USA In this fifth interview of our series “Portrait of Duchenne,” La Force DMD talks with [...]

Articles récents

  • The global day of giving
  • EMBARK, gene therapy for the treatment of DMD
  • Part B of MOMENTUM study of SRP-5051 in patients with DMD
  • World Duchenne Awareness Day 2021
  • ENDEAVOR, gene therapy for DMD

Catégories

  • Fundraising
  • in the Medias
  • News
  • Research
  • Testimonial
  • Treatments

+

Restez informé

    LA Force - Dystrophie musculaire de Duchenne

    La Force dmd - Tous droits réservés - Organisme de bienfaisance enregistré : 817683568RP0001
    La Force dmd La Force dmd
    • S’informer
      • Frequently Asked Questions
    • Make a Donation
    • Agir
      • Quick guige – Management of DMD
      • Take action – What’s your genetic profile?
      • Take action – Subscribe to registries
    • Aller plus loin
      • Go further – How can you access a new treatment?
      • Go further – How do researchers test new treatments?
      • Go further – How are drugs approved for use in Canada?
      • Go further – Who decides to reimburse drug costs?
    • Blog
    • About us
    • Contact-us